Abstract
Transplantation of insulin-producing cells offers a promising therapy to treat diabetes. However, due to the limited number of donor islet cells available, researchers are looking for different sources of pancreatic islet progenitor or stem cells. A stem cell with extensive proliferative ability may provide a valuable source of islet progenitor cells. Several studies have demonstrated that a progenitor/stem-cell population can be expanded in vitro to generate large numbers of islet progenitor cells. However, efficient and directed differentiation of these cells to an endocrine pancreatic lineage has been difficult to achieve. We discuss here various pancreatic islet stem cells that we and others have obtained from embryonic, fetal or adult human tissues. We review the progress that has been achieved with pancreatic islet progenitor cell differentiation in the last 2 decades and discuss how close we are to translate this research to the clinics.
Keywords: hESC differentiation, Nestin positive cells, fetal pancreas, Transplantation, multipotent adult progenitor cells
Current Stem Cell Research & Therapy
Title: Stem-Cell Therapy for Diabetes Cure: How Close are We?
Volume: 1 Issue: 3
Author(s): Anandwardhan A. Hardikar, Justin G. Lees, Kuldip S. Sidhu, Emily Colvin and Bernard E. Tuch
Affiliation:
Keywords: hESC differentiation, Nestin positive cells, fetal pancreas, Transplantation, multipotent adult progenitor cells
Abstract: Transplantation of insulin-producing cells offers a promising therapy to treat diabetes. However, due to the limited number of donor islet cells available, researchers are looking for different sources of pancreatic islet progenitor or stem cells. A stem cell with extensive proliferative ability may provide a valuable source of islet progenitor cells. Several studies have demonstrated that a progenitor/stem-cell population can be expanded in vitro to generate large numbers of islet progenitor cells. However, efficient and directed differentiation of these cells to an endocrine pancreatic lineage has been difficult to achieve. We discuss here various pancreatic islet stem cells that we and others have obtained from embryonic, fetal or adult human tissues. We review the progress that has been achieved with pancreatic islet progenitor cell differentiation in the last 2 decades and discuss how close we are to translate this research to the clinics.
Export Options
About this article
Cite this article as:
Hardikar A. Anandwardhan, Lees G. Justin, Sidhu S. Kuldip, Colvin Emily and Tuch E. Bernard, Stem-Cell Therapy for Diabetes Cure: How Close are We?, Current Stem Cell Research & Therapy 2006; 1 (3) . https://dx.doi.org/10.2174/157488806778226830
DOI https://dx.doi.org/10.2174/157488806778226830 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Novel Non-rodent Models of Kidney Disease
Current Molecular Medicine Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease
Current Medicinal Chemistry Orphan Nuclear Receptor Modulators
Current Topics in Medicinal Chemistry Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing
Reviews on Recent Clinical Trials Advanced QSAR Methods Evaluated Polycyclic Aromatic Compounds Duality as Drugs and Inductors in Psychiatric Disorders
Current Organic Chemistry Patent Selections
Recent Patents on Biotechnology Evaluation of BMP-2 Minicircle DNA for Enhanced Bone Engineering and Regeneration
Current Gene Therapy Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology The Innate Immunity: Roles for New Antifungal and Antibacterial Peptides Secreted by Chromaffin Granules from the Adrenal Medulla
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)
Current Pharmaceutical Design Phase Transition Regulated by Photo-Controlled Molecular Recognition of Alpha- Cyclodextrin
Current Organic Chemistry Therapeutic Targets in Polycystic Liver Disease
Current Drug Targets Modulating the Amyloidogenesis of α-Synuclein
Current Neuropharmacology Evaluating the Efficacy of Intra-articular Injections of Platelet Rich Plasma (PRP) in Rheumatoid Arthritis Patients and its Impact on Inflammatory Cytokines, Disease Activity and Quality of Life
Current Rheumatology Reviews Editorial [Hot Topic: Sepsis (Guest Editor: David E. Joyce)]
Current Drug Targets Extruded Product Based on Oat and Fenugreek and their Storage Stability
Current Nutrition & Food Science Connecting the Dots: Molecular and Epigenetic Mechanisms in Type 2 Diabetes
Current Diabetes Reviews Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Current Cancer Drug Targets Advances on Magnetic Nanocarriers Based on Natural Polymers
Current Pharmaceutical Design